Abstract：【Objective】To investigate the clinical efficacy of Yinchenhao Decoction in the treatment of diabetes foot after operation.【Methods】The clinical data of 95 patients with diabetes foot who underwent surgical treatment in our hospital from January to December 2023 were retrospectively analyzed. According to the different treatment methods, they were divided into the control group (n=47, conventional treatment) and the observation group (n=48, conventional treatment + Yinchenhao Decoction modified treatment). We compared the clinical efficacy, postoperative recovery (bed rest time, bed rest time, anal exhaust time, hospital stay), wound improvement (wound area and depth, granulation tissue growth degree, wound healing time), and incidence of adverse reactions between two groups,and the symptom scores and serum inflammatory factors[ C-reactive protein(CRP), tumor necrosis factor-α(TNF-α), interleukin-4(IL-4), interleukin-5(IL-5)],blood glucose [fasting blood glucose(FPG), glycated hemoglobin (HbA1c)] and the levels of hemorheological indicators[erythrocyte sedimentation rate (ESR), fibrinogen (Fib), and plasma viscosity (PV) ]before and after treatment were statistically analyzed for both groups.【Results】The total effective rate of the observation group was 93.75%, significantly higher than the control group's 78.72% (P<0.05). Compared with the control group, the observation group had a shorter postoperative recovery time (P<0.05). After treatment, the wound area and depth of both groups decreased, and the observation group showed a more significant decrease (P<0.05); The growth degree of granulation tissue in the observation group was greater than that in the control group, and the wound healing time was shorter than that in the control group (P<0.05). After treatment, the levels of the symptom scores FPG, HbA1c, CRP, TNF-α, ESR, Fib, and PV for both groups were all reduced, and the observation group was lower than the control group (P<0.05); The levels of IL-4 and IL-5 both increased, and the observation group was higher than the control group (P<0.05). Both groups of patients showed no significant adverse reactions.【Conclusion】Yinchenhao Decoction can promote postoperative recovery and wound repair of diabetes foot, control blood sugar level, relieve symptoms, alleviate inflammatory reaction, improve hemorheology, improve efficacy, and will not increase the incidence of adverse reactions.
[1] 易纪杰,胡仕祥,赵哲,等.茵陈蒿汤加减治疗急性重症胆管炎胆道减压引流术后疗效的Meta分析[J].中国中西医结合急救杂志,2021,28(2):178-183. [2] 邹增城,郭文海,李永伟.小柴胡汤合茵陈蒿汤加减辅治肝动脉化疗栓塞术后综合征临床观察[J].实用中医药杂志,2022,38(7):1127-1129. [3] 姚彪,胡玥,张媞,等.腹腔镜胆囊切除术后应用茵陈蒿汤合大柴胡汤加减临床观察[J].实用中医药杂志,2023,39(3):442-444. [4] 中华医学会糖尿病学分会,中华医学会感染病学分会,中华医学会组织修复与再生分会.中国糖尿病足防治指南(2019版)(Ⅲ)[J].中华糖尿病杂志,2019,11(4):238-247. [5] 中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会.糖尿病足病中医病证结合诊疗指南[J].中医杂志,2021,62(12):1099-1104. [6] 中国微循环学会周围血管疾病专业委员会糖尿病足学组.糖尿病足创面修复治疗专家共识[J].中华糖尿病杂志,2018,10 (5): 305-309. [7] DU Y Q, WANG J, FAN W J,et al. Preclinical study of diabetic foot ulcers: From pathogenesis to vivo/vitro models and clinical therapeutic transformation[J].Int Wound J,2023,20(10):4394-4409. [8] MPONPONSUO K, SIBBALD R G, SOMAYAJI R. A comprehensive review of the pathogenesis, diagnosis, and management of diabetic foot infections[J].Adv Skin Wound Care,2021,34(11):574-581. [9] AROSI I, HINER G, RAJBHANDARI S. Pathogenesis and treatment of callus in the diabetic foot[J].Curr Diabetes Rev,2016,12(3):179-183. [10] 马辉,李铮,张莹雯,等.茵陈蒿汤合龙胆泻肝汤辅助治疗急性胰腺炎(肝胆湿热证)的疗效观察[J].中国中医急症,2021,30(6):1037-1039. [11] 周娅微,董晓斐,彭研献,等.茵陈蒿汤外洗联合布拉氏酵母菌散和光疗治疗新生儿高胆红素血症的临床研究[J].现代生物医学进展,2022,22(3):506-509. [12] 顾文.茵陈蒿汤联合肠道益生菌治疗非酒精性脂肪性肝病的疗效探讨[J].中国中西医结合消化杂志,2021,29(10):745-748. [13] 孙帅玲,马晓北.基于网络药理学探讨茵陈蒿汤治疗高脂血症作用机制[J].陕西中医,2021,42(12):1793-1797.
2024, Vol. 41 
